Hereditary breast-ovarian cancer syndrome
In a family with a tendency to hereditary breast cancer, if there are two or more ovarian cancer patients among the breast cancer patient or their first or second degree blood relatives, then this family belongs to the hereditary breast cancer-ovarian cancer syndrome family. In 1992, three clear hereditary ovarian cancer syndromes were defined: ① Hereditary non-polyposis colorectal cancer syndrome (i.e. Lynch type II). ② Genetic locus-specific ovarian cancer syndrome. ③ Hereditary breast cancer-ovarian cancer syndrome. The latter is the most common of the three syndromes.
-
Site of disease:
Ovarian bowel -
Infectious :
Not contagious -
Frequent population:
female -
Related symptoms:
Breast lumps breast hardening breast pain breast lumps breast hardening -
Concurrent disease:
Related Drugs
Anastrozole tablets
Indication: It is suitable for postmenopausal women with advanced breast cancer that cannot be controlled by tamoxifen and other anti-estrogen therapies. For patients with negative estrogen receptors, if they show a positive clinical response to tamoxifen, this product can be considered.
Manufacturer:
Yangtze River Pharmaceutical (Group) Co., Ltd.
Medroxyprogesterone acetate dispersible tablets
Indication: Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.
Medroxyprogesterone acetate capsules
Indication: Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.
Manufacturer:
Nanjing Cuccess Pharmaceutical Co., Ltd.
Chloroquine Capsules
Indication: Treatment of breast cancer, non-small cell lung cancer, etc.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.
Tamoxifen Citrate Tablets
Indication: 1. To treat recurrent and metastatic breast cancer in women; 2. To be used as an adjuvant treatment for metastatic breast cancer after surgery to prevent recurrence.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Related Ingredients
-
Anastrozole list
120511-73-1 -
Medroxyprogesterone Acetate list
71-58-9 -
Tamoxifen citrate list
54965-24-1